A Phase 2, single-arm study of bempegaldesleukin (NKTR-214) in combination with nivolumab in cisplatin ineligible, locally advanced or metastatic urothelial cancer patients

Project: Research

StatusActive
Effective start/end date24/06/1923/06/24

Keywords

  • clinical trial
  • treatment efficacy
  • urothelial cancer
  • phase 2 study